Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Potti

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Environmental Toxicology and Pharmacology|July 26, 2011
Exposure to pesticides increases levels of uPA and uPAR in pre-malignant human prostate cellsAnil Potti, Inder Sehgal
Expert Review of Molecular Diagnostics|November 21, 2007
Genomic signatures individualize therapeutic decisions in non-small-cell lung cancerAriel Anguiano, Anil Potti
Annals of Surgical Oncology|November 4, 2011
A pathway-based approach to identify molecular biomarkers in cancerMarvaretta Stevenson, Anil Potti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Tyrosine kinase inhibitors in renal cell carcinomaAnil Potti, Daniel J George
Nature Reviews. Genetics|July 4, 2007
Mining gene expression profiles: expression signatures as cancer phenotypesJoseph R Nevins, Anil Potti
Current Oncology Reports|June 11, 2009
Translating genomics into clinical practice: applications in lung cancerAubrey Jolly Graham, Anil Potti
Expert Opinion on Biological Therapy|August 27, 2005
Epidermal growth factor inhibition in solid tumoursApar Kishor Ganti, Anil Potti
Southern Medical Journal|July 30, 2002
Spinal epidural abscess after corticosteroid injectionsVijay K Koka, Anil Potti
Expert Opinion on Biological Therapy|June 30, 2006
Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the futureAnil Potti, Apar Kishor Ganti
Current Opinion in Genetics & Development|March 15, 2008
Utilization of genomic signatures to direct use of primary chemotherapyAnil Potti, Joseph R Nevins
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Environmental Toxicology and Pharmacology|July 26, 2011
Exposure to pesticides increases levels of uPA and uPAR in pre-malignant human prostate cellsAnil Potti, Inder Sehgal
Expert Review of Molecular Diagnostics|November 21, 2007
Genomic signatures individualize therapeutic decisions in non-small-cell lung cancerAriel Anguiano, Anil Potti
Annals of Surgical Oncology|November 4, 2011
A pathway-based approach to identify molecular biomarkers in cancerMarvaretta Stevenson, Anil Potti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Tyrosine kinase inhibitors in renal cell carcinomaAnil Potti, Daniel J George
Nature Reviews. Genetics|July 4, 2007
Mining gene expression profiles: expression signatures as cancer phenotypesJoseph R Nevins, Anil Potti
Current Oncology Reports|June 11, 2009
Translating genomics into clinical practice: applications in lung cancerAubrey Jolly Graham, Anil Potti
Expert Opinion on Biological Therapy|August 27, 2005
Epidermal growth factor inhibition in solid tumoursApar Kishor Ganti, Anil Potti
Southern Medical Journal|July 30, 2002
Spinal epidural abscess after corticosteroid injectionsVijay K Koka, Anil Potti
Expert Opinion on Biological Therapy|June 30, 2006
Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the futureAnil Potti, Apar Kishor Ganti
Current Opinion in Genetics & Development|March 15, 2008
Utilization of genomic signatures to direct use of primary chemotherapyAnil Potti, Joseph R Nevins
Pageof 10